Kim et al., examining the possibility of selectively targeting specific subtypes of NSCLC, found that the co-mutation KRAS/LKB1 was sufficient to make these cells dependent to the coatomer complex I (COPI) lysosome acidification. Here, KRAS is linked to non-small cell lung carcinoma.